Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Tabakoff

Showing results (121-130 of 244) with videos related to

Pageof 25
Sort By:
Physiology & Behavior|January 1, 1985
Pentobarbital-induced drinking does not rely on a renal dipsogenK E Asin, D Wirtshafter, B Tabakoff
Molecular Pharmacology|July 1, 1973
Enzymatic reduction of "biogenic" aldehydes in brainB Tabakoff, R Anderson, S G Alivisatos
Seminars in Liver Disease|February 1, 1988
Is ethanol a discriminating substance?B Tabakoff, P L Hoffman, A McLaughlin
Alcoholism, Clinical and Experimental Research|September 3, 1998
An initial study of the relationship between platelet adenylyl cyclase activity and alcohol use disorder criteriaH Ikeda, J A Menninger, B Tabakoff
Experimental Neurology|May 1, 1979
Neuronal deficits in mice following prenatal exposure to phenobarbitalJ Yanai, L Rosselli-Austin, B Tabakoff
Alcoholism, Clinical and Experimental Research|October 1, 1991
Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranesK Hellevuo, P L Hoffman, B Tabakoff
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressinG Szabó, B Tabakoff, P L Hoffman
Molecular Pharmacology|March 1, 1990
Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brainJ R Dave, B Tabakoff, P L Hoffman
Life Sciences|March 7, 1983
Vasopressin maintenance of ethanol tolerance requires intact brain noradrenergic systemsP L Hoffman, C L Melchior, B Tabakoff
Experientia|April 15, 1975
Inhibition of liver aldehyde dehydrogenase by pyrogallol and related compoundsJ A Rubenstein, M A Collins, B Tabakoff
Pageof 25

Showing results (121-130 of 244) with videos related to

Sort By:
Pageof 25
Physiology & Behavior|January 1, 1985
Pentobarbital-induced drinking does not rely on a renal dipsogenK E Asin, D Wirtshafter, B Tabakoff
Molecular Pharmacology|July 1, 1973
Enzymatic reduction of "biogenic" aldehydes in brainB Tabakoff, R Anderson, S G Alivisatos
Seminars in Liver Disease|February 1, 1988
Is ethanol a discriminating substance?B Tabakoff, P L Hoffman, A McLaughlin
Alcoholism, Clinical and Experimental Research|September 3, 1998
An initial study of the relationship between platelet adenylyl cyclase activity and alcohol use disorder criteriaH Ikeda, J A Menninger, B Tabakoff
Experimental Neurology|May 1, 1979
Neuronal deficits in mice following prenatal exposure to phenobarbitalJ Yanai, L Rosselli-Austin, B Tabakoff
Alcoholism, Clinical and Experimental Research|October 1, 1991
Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranesK Hellevuo, P L Hoffman, B Tabakoff
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressinG Szabó, B Tabakoff, P L Hoffman
Molecular Pharmacology|March 1, 1990
Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brainJ R Dave, B Tabakoff, P L Hoffman
Life Sciences|March 7, 1983
Vasopressin maintenance of ethanol tolerance requires intact brain noradrenergic systemsP L Hoffman, C L Melchior, B Tabakoff
Experientia|April 15, 1975
Inhibition of liver aldehyde dehydrogenase by pyrogallol and related compoundsJ A Rubenstein, M A Collins, B Tabakoff
Pageof 25